Table of Contents Author Guidelines Submit a Manuscript
Complexity
Volume 2017 (2017), Article ID 5297406, 13 pages
https://doi.org/10.1155/2017/5297406
Review Article

A Structured Review of Quantitative Models of the Pharmaceutical Supply Chain

1Universidad del Rosario, Escuela de Administración, Bogotá, Colombia
2Universidad de La Sabana, School of Engineering, Group Logistic Systems, Campus Universitario, Puente del Común, Km. 7, Autopista Norte, Bogotá, Colombia
3University of Lyon, University Jean Monnet-St-Etienne, LASPI, EA3059, 42023 Saint-Etienne, France

Correspondence should be addressed to Carlos Franco

Received 6 January 2017; Revised 2 November 2017; Accepted 6 November 2017; Published 5 December 2017

Academic Editor: Michele Scarpiniti

Copyright © 2017 Carlos Franco and Edgar Alfonso-Lizarazo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Ahmadiani and S. Nikfar, “Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective,” DARU Journal of Pharmaceutical Sciences, vol. 24, article 13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Rankin, J. D. Quickand, and S. Muziki, Operational Principles for Good Pharmaceutical Procurement, Geneva, Switzerland, 1999.
  3. L. Burns, The Health Care Value Chain Producers, Purchasers and Providers, Wharton School Colleagues, 2002.
  4. S. H. Chung and C. Kwon, “Integrated supply chain management for perishable products: Dynamics and oligopolistic competition perspectives with application to pharmaceuticals,” International Journal of Production Economics, vol. 179, pp. 117–129, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. R. T. Sousa, S. Liu, L. G. Papageorgiou, and N. Shah, “Global supply chain planning for pharmaceuticals,” Chemical Engineering Research and Design, vol. 89, no. 11, pp. 2396–2409, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. R. B. Handfield and E. L. Nichols, Introduction to Supply Chain Management, Prentice Hall, New Jersey, NJ, USA, 1999.
  7. S. A. Narayana, R. Kumar Pati, and P. Vrat, “Managerial research on the pharmaceutical supply chain—a critical review and some insights for future directions,” Journal of Purchasing and Supply Management, vol. 20, no. 1, pp. 18–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. WHO, “The World Health Report Health System Financing: the path to universal coverage,” Tech. Rep., World Health Organization (WHO), 2010. View at Google Scholar
  9. J. Little and B. Coughlan, “Optimal inventory policy within hospital space constraints,” Health Care Management Science, vol. 11, no. 2, pp. 177–183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Aptel and H. Pourjalali, “Improving activities and decreasing costs of logistics in hospitals: a comparison of U.S. and French hospitals,” The International Journal of Accounting, vol. 36, no. 1, pp. 65–90, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Z. Karaesmen, A. Scheller–Wolf, and B. Deniz, “Planning production and inventories in the extended enterprise,” in Managing Perishable and Aging Inventories: Review and Future Research Directions, pp. 393–436, Springer, 2011. View at Google Scholar · View at Scopus
  12. J. M. Laínez, E. Schaefer, and G. V. Reklaitis, “Challenges and opportunities in enterprise-wide optimization in the pharmaceutical industry,” Computers & Chemical Engineering, vol. 47, pp. 19–28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. I.-W. G. Kwon, S.-H. Kim, and D. G. Martin, “Healthcare supply chain management; strategic areas for quality and financial improvement,” Technological Forecasting & Social Change, vol. 113, pp. 422–428, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. S. A. Narayana, R. K. Pati, and P. Vrat, “Research on management issues in the pharmaceutical industry: a literature review,” International Journal of Pharmaceutical and Healthcare Marketing, vol. 6, no. 4, pp. 351–375, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Privett and D. Gonsalvez, “The top ten global health supply chain issues: perspectives from the field,” Operations Research for Health Care, vol. 3, no. 4, pp. 226–230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Alverson, “Beyond purchasing—managing hospital inventory,” in Pharmacy Management, Advanstar Communications Inc, 2003. View at Google Scholar
  17. N. Shah, “Pharmaceutical supply chains: key issues and strategies for optimisation,” Computers & Chemical Engineering, vol. 28, no. 6-7, pp. 929–941, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Volland, A. Fügener, J. Schoenfelder, and J. O. Brunner, “Material logistics in hospitals: a literature review,” OMEGA, vol. 69, pp. 82–101, 2017. View at Publisher · View at Google Scholar · View at Scopus
  19. R. H. Ballou, “Business logistics: importance and some research opportunities,” Gestão & Produção, vol. 4, no. 2, pp. 117–129, 1997. View at Publisher · View at Google Scholar
  20. G. E. Rotstein, L. G. Papageorgiou, N. Shah, D. C. Murphy, and R. Mustafa, “A product portfolio approach in the pharmaceutical industry,” Computers & Chemical Engineering, vol. 23, supplement 1, pp. S883–S886, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. L. G. Papageorgiou, G. E. Rotstein, and N. Shah, “Strategic supply chain optimization for the pharmaceutical industries,” Industrial & Engineering Chemistry Research, vol. 40, no. 1, pp. 275–286, 2001. View at Publisher · View at Google Scholar
  22. A. A. Levis and L. G. Papageorgiou, “Multi-site capacity planning for the pharmaceutical industry using mathematical programming,” Computer Aided Chemical Engineering, vol. 14, pp. 1097–1102, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. A. Levis and L. G. Papageorgiou, “A hierarchical solution approach for multi-site capacity planning under uncertainty in the pharmaceutical industry,” Computers & Chemical Engineering, vol. 28, no. 5, pp. 707–725, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Gatica, L. G. Papageorgiou, and N. Shah, “Capacity planning under uncertainty for the pharmaceutical industry,” Chemical Engineering Research and Design, vol. 81, no. 6, pp. 665–678, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Gatica, L. Papageorgiou, and N. Shah, “An aggregation approach for capacity planning under uncertainty for the pharmaceutical industry,” in Proceedings of the FOCAPO 2003 Conference, Florida, Fla, USA, 2003.
  26. C. G. Chambers, E. M. Snir, and A. Ata, “The use of flexible manufacturing capacity in pharmaceutical product introductions,” Decision Sciences, vol. 40, no. 2, pp. 243–268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Susarla and I. A. Karimi, “Integrated supply chain planning for multinational pharmaceutical enterprises,” Computers & Chemical Engineering, vol. 42, pp. 168–177, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Mousazadeh, S. A. Torabi, and B. Zahiri, “A robust possibilistic programming approach for pharmaceutical supply chain network design,” Computers & Chemical Engineering, vol. 82, pp. 115–128, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. A. B. Almarsdóttir and J. M. Traulsen, “Cost-containment as part of pharmaceutical policy,” Pharmacy world and science, vol. 27, no. 3, pp. 144–148, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Şatir and D. Cengiz, “Medicinal inventory control in a university health centre,” Journal of the Operational Research Society, vol. 38, no. 5, pp. 387–395, 1987. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Vincent and M. Ranton, “Hospital pharmacy inventory management: economic order quantity model with space limitation,” Hospital Materiel Management Quarterly, vol. 5, no. 3, pp. 82–86, 1984. View at Google Scholar
  32. N. Dellaert and E. Van De Poel, “Global inventory control in an academic hospital,” International Journal of Production Economics, vol. 46-47, pp. 277–284, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Kelle, J. Woosley, and H. Schneider, “Pharmaceutical supply chain specifics and inventory solutions for a hospital case,” Operations Research for Health Care, vol. 1, no. 2-3, pp. 54–63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. R. Vila-Parrish, J. S. Ivy, and R. E. King, “A simulation-based approach for inventory modeling of perishable pharmaceuticals,” in Proceedings of the 2008 Winter Simulation Conference, WSC 2008, pp. 1532–1538, Miami, Fla, USA, December 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Wu, M. D. Rossetti, and J. E. Tepper, “Possibility of inventory pooling in China's public hospital and appraisal about its performance,” Applied Mathematical Modelling, vol. 39, no. 23-24, pp. 7277–7290, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. L.-C. Wang, C.-Y. Cheng, Y.-T. Tseng, and Y.-F. Liu, “Demand-pull replenishment model for hospital inventory management: a dynamic buffer-adjustment approach,” International Journal of Production Research, vol. 53, no. 24, pp. 7533–7546, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. Ö. E. Çakici, H. Groenevelt, and A. Seidmann, “Using RFID for the management of pharmaceutical inventory-system optimization and shrinkage control,” Decision Support Systems, vol. 51, no. 4, pp. 842–852, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M.-P. Schapranow, J. Müller, A. Zeier, and H. Plattner, “Costs of authentic pharmaceuticals: research on qualitative and quantitative aspects of enabling anti-counterfeiting in RFID-aided supply chains,” Personal and Ubiquitous Computing, vol. 16, no. 3, pp. 271–289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Candan and H. R. Yazgan, “A novel approach for inventory problem in the pharmaceutical supply chain,” DARU Journal of Pharmaceutical Sciences, vol. 24, article 4, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. W. J. Guerrero, T. G. Yeung, and C. Guéret, “Joint-optimization of inventory policies on a multi-product multi-echelon pharmaceutical system with batching and ordering constraints,” European Journal of Operational Research, vol. 231, no. 1, pp. 98–108, 2013. View at Publisher · View at Google Scholar · View at MathSciNet
  41. J. Rappold, B. Van Roo, C. Di Martinelly, and F. Riane, “An inventory optimization model to support operating room schedules,” Supply Chain Forum: An International Journal, vol. 12, no. 1, pp. 56–69, 2011. View at Google Scholar
  42. M. Bijvank and I. F. A. Vis, “Inventory control for point-of-use locations in hospitals,” Journal of the Operational Research Society, vol. 63, no. 4, pp. 497–510, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Kim, “An integrated supply chain management system: a case study in healthcare sector,” in E-Commerce and Web Technologies, vol. 3590 of Lecture Notes in Computer Science, pp. 218–227, Springer, Berlin, GErmany, 2005. View at Publisher · View at Google Scholar
  44. A. Baboli, J. Fondrevelle, R. Tavakkoli-Moghaddam, and A. Mehrabi, “A replenishment policy based on joint optimization in a downstream pharmaceutical supply chain: centralized vs. decentralized replenishment,” The International Journal of Advanced Manufacturing Technology, vol. 57, no. 1–4, pp. 367–378, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Azzi, A. Persona, F. Sgarbossa, and M. Bonin, “Drug inventory management and distribution: outsourcing logistics to third-party providers,” Strategic Outsourcing: An International Journal, vol. 6, no. 1, pp. 48–64, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Hassan, A. Baboli, A. Guinet, G. Leboucher, and M. Brandon, “Re-organizing the pharmaceutical supply chain downstream: implementation a new pharmacy,” IFAC Proceedings Volumes, vol. 39, no. 3, pp. 727–732, 2006. View at Publisher · View at Google Scholar
  47. R. Uthayakumar and S. Priyan, “Pharmaceutical supply chain and inventory management strategies: optimization for a pharmaceutical company and a hospital,” Operations Research for Health Care, vol. 2, no. 3, pp. 52–64, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Priyan and R. Uthayakumar, “Optimal inventory management strategies for pharmaceutical company and hospital supply chain in a fuzzy-stochastic environment,” Operations Research for Health Care, vol. 3, no. 4, pp. 177–190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Zhao, C. Xiong, S. Gavirneni, and A. Fein, “Fee-for-service contracts in pharmaceutical distribution supply chains: design, analysis, and management,” Manufacturing and Service Operations Management, vol. 14, no. 4, pp. 685–699, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Nicholson, A. J. Vakharia, and S. Selcuk Erenguc, “Outsourcing inventory management decisions in healthcare: models and application,” European Journal of Operational Research, vol. 154, no. 1, pp. 271–290, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Sinha and K. F. Matta, “Multiechelon (R, S) Inventory Model,” Decision Sciences, vol. 22, no. 3, pp. 484–499, 1991. View at Publisher · View at Google Scholar · View at Scopus
  52. D. F. Rogers and S. Tsubakitani, “Inventory positioning/partitioning for backorders optimization for a class of multi‐echelon inventory problems,” Decision Sciences, vol. 22, no. 3, pp. 536–558, 1991. View at Publisher · View at Google Scholar · View at Scopus
  53. D. A. Balcázar-Camacho, C. A. López-Bello, and W. Adarme-Jaimes, “Strategic guidelines for supply chain coordination in healthcare and a mathematical model as a proposed mechanism for the measurement of coordination effects,” DYNA, vol. 83, no. 197, pp. 204–212, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Stecca, I. Baffo, and T. Kaihara, “Design and operation of strategic inventory control system for drug delivery in healthcare industry,” IFAC-PapersOnLine, vol. 49, no. 12, pp. 904–909, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Dutta, R. Fourer, A. Majumdar, and D. Dutta, “An optimization-based decision support system for strategic planning in a process industry: the case of a pharmaceutical company in India,” International Journal of Production Economics, vol. 106, no. 1, pp. 92–103, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Jetly, C. L. Rossetti, and R. Handfield, “A multi-agent simulation of the pharmaceutical supply chain,” Journal of Simulation, vol. 6, no. 4, pp. 215–226, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. L. G. Eberle, H. Sugiyama, and R. Schmidt, “Improving lead time of pharmaceutical production processes using Monte Carlo simulation,” Computers & Chemical Engineering, vol. 68, pp. 255–263, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. A. H. Masoumi, M. Yu, and A. Nagurney, “A supply chain generalized network oligopoly model for pharmaceuticals under brand differentiation and perishability,” Transportation Research Part E: Logistics and Transportation Review, vol. 48, no. 4, pp. 762–780, 2012. View at Google Scholar
  59. K. R. N. Hansen and M. Grunow, “Planning operations before market launch for balancing time-to-market and risks in pharmaceutical supply chains,” International Journal of Production Economics, vol. 161, pp. 129–139, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Rego, J. Claro, and J. Pinho de Sousa, “A hybrid approach for integrated healthcare cooperative purchasing and supply chain configuration,” Health Care Management Science, vol. 17, no. 4, pp. 303–320, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Grunow, H.-O. Günther, and G. Yang, “Plant co-ordination in pharmaceutics supply networks,” OR Spectrum, vol. 25, no. 1, pp. 109–141, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. A. C. S. Amaro and A. P. F. D. Barbosa-Póvoa, “Planning and scheduling of industrial supply chains with reverse flows: a real pharmaceutical case study,” Computers & Chemical Engineering, vol. 32, no. 11, pp. 2606–2625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Weraikat, M. K. Zanjani, and N. Lehoux, “Coordinating a green reverse supply chain in pharmaceutical sector by negotiation,” Computers & Industrial Engineering, vol. 93, pp. 67–77, 2016. View at Publisher · View at Google Scholar · View at Scopus
  64. L.-H. Shih and Y.-T. Lin, “Multicriteria optimization for infectious medical waste collection system planning,” Practice Periodical of Hazardous, Toxic, and Radioactive Waste Management, vol. 7, no. 2, pp. 78–85, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. D. Weraikat, M. K. Zanjani, and N. Lehoux, “Two-echelon pharmaceutical reverse supply chain coordination with customers incentives,” International Journal of Production Economics, vol. 176, pp. 41–52, 2016. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Xie and L. Breen, “Greening community pharmaceutical supply chain in UK: a cross boundary approach,” Supply Chain Management Review, vol. 17, no. 1, pp. 40–53, 2012. View at Publisher · View at Google Scholar · View at Scopus